NCT03004274

Brief Summary

The goal of this study is to assess whether running deep wound stiches will be superior to deep interrupted stiches in body contouring surgeries in massive weight loss patients. This is a split-wound study, thereby providing an internal control within each wound. Each side of the wound will be randomized to receive one of the two suturing techniques. Patients and raters will be blinded to the suture technique used in both wound-halfs.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

December 18, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 28, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Last Updated

December 29, 2016

Status Verified

December 1, 2016

Enrollment Period

1 year

First QC Date

December 18, 2016

Last Update Submit

December 27, 2016

Conditions

Outcome Measures

Primary Outcomes (4)

  • Scar cosmesis

    The primary outcome measure of this study will be the evaluation of the scar quality. This outcome will be assessed by the Patient and Observer Scar Assessment Scale (POSAS). The patient and four blinded raters will assess the scars.

    15 days

  • Scar cosmesis

    The primary outcome measure of this study will be the evaluation of the scar quality. This outcome will be assessed by the Patient and Observer Scar Assessment Scale (POSAS). The patient and four blinded raters will assess the scars.

    1.5 months

  • Scar cosmesis

    The primary outcome measure of this study will be the evaluation of the scar quality. This outcome will be assessed by the Patient and Observer Scar Assessment Scale (POSAS). The patient and four blinded raters will assess the scars.

    3 months

  • Scar cosmesis

    The primary outcome measure of this study will be the evaluation of the scar quality. This outcome will be assessed by the Patient and Observer Scar Assessment Scale (POSAS). The patient and four blinded raters will assess the scars.

    6 months

Secondary Outcomes (8)

  • Measurement of Scar Width

    3 months

  • Measurement of Scar Width

    6 months

  • Adverse Events

    15 days

  • Adverse Events

    1.5 months

  • Adverse Events

    3 months

  • +3 more secondary outcomes

Study Arms (2)

Running sutures

ACTIVE COMPARATOR

Deep layers will be closed using running sutures

Other: Running sutures

Interrupted sutures

EXPERIMENTAL

Deep layers will be closed using interrupted sutures

Other: Interrupted sutures

Interventions

Running sutures
Interrupted sutures

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and over
  • Brachioplasty, Tighplasty, abdominoplasty, circumferential dermolipectomy in a massive weight loss patient
  • The subjects are in good health
  • The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

You may not qualify if:

  • Under 18 years of age
  • Subjects who are unable to understand the protocol or to give informed consent
  • Subjects with mental illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Josph Hospital

Paris, Paris, 75014, France

RECRUITING

MeSH Terms

Conditions

Weight Loss

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

December 18, 2016

First Posted

December 28, 2016

Study Start

December 1, 2016

Primary Completion

December 1, 2017

Last Updated

December 29, 2016

Record last verified: 2016-12

Locations